The immune response in AIH is believed to be initiated by the presentation of self-antigenic peptides, as yet unknown, to the T cell receptor (TCR) of uncommitted naive CD4 T-helper (Th0) lymphocytes. This evidence concerns the gene CD4 and autoimmune hepatitis.